TP53 and neoplasm: As reported for the Trp53 study (Jongsma et al., 2008), tumour histology was predominantly sarcomatoid (Kukuyan et al., 2019) or biphasic (Badhai et al., 2020) and off-target tumours were again frequently detected in both studies.